CTOs on the Move

Pathalys

www.pathalys.com

 
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pathalys.com
  • 4242 Six Forks Road Suite 820
    Raleigh, NC USA 27609
  • Phone: n/a

Executives

Name Title Contact Details
David Banks
Senior Vice President of Technical Operations Profile

Similar Companies

Immune Tolerance Network

Immune Tolerance Network is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Supply Chain Logistics

Supply Chain Logistics is a Utica, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaLeaders

PharmaLeaders is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpine Solutions

Alpine Solutions is a pioneer in the medical industry for the repair and sales of electronics, imaging equipment, CT & MRI parts, medical drives and etc.

Agios

Developing breakthrough medicines for patients with cancer and rare genetic diseases is incredibly important, and so difficult. It takes great science. But it also takes an environment where people care – about the work, about each other, and about patients. At Agios, we`re always looking for the sweet spot between exhilaration and anxiety – while being respectful, kind and connected with each other so we can flourish. At our core, we`re a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients. We`re a science-driven, global organization that`s built a discovery platform on our expertise across three major focus areas: cancer metabolism, rare genetic diseases and metabolic immuno-oncology. And we care. A lot. Patients are counting on us, and we`re driven by a sense of urgency to help. We challenge ourselves to think big and welcome different perspectives and backgrounds. And we deliver. We have two approved oncology precision medicines and multiple first-in-class investigational therapies in development. So far. Through it all, we are propelled by our connections. We believe in our people to be…just who they are. We believe in our work and in each other – in enjoying this journey together so that we can achieve the Other Side of Possible.